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ABSTRACT 
Objective: The Maternal Mental Health in Canada, 2018/2019 survey reported that 18% of 
7,085 mothers who recently gave birth reported “feelings consistent with postpartum depression” 
based on scores ≥7 on a 5-item version of the Edinburgh Postpartum Depression Scale (EPDS-
5). The EPDS-5 was designed as a screening questionnaire, not to classify disorders or estimate 
prevalence; the extent to which EPDS-5 results reflect depression prevalence is unknown. We 
investigated EPDS-5 ≥7 performance relative to major depression prevalence based on a 
validated diagnostic interview, the Structured Clinical Interview for DSM (SCID). 
Methods: We searched Medline, Medline In-Process & Other Non-Indexed Citations, 
PsycINFO, and the Web of Science Core Collection through June 2016 for studies with datasets 
with item response data to calculate EPDS-5 scores and that used the SCID to ascertain 
depression status. We conducted an individual participant data meta-analysis to estimate pooled 
percentage of EPDS-5 ≥7, pooled SCID major depression prevalence, and the pooled difference 
in prevalence. 
Results: 3,958 participants from 19 primary studies were included. Pooled prevalence of SCID 
major depression was 9.2% (95% confidence interval [CI] 6.0% to 13.7%), pooled percentage of 
participants with EPDS-5 ≥7 was 16.2% (95% CI 10.7% to 23.8%), and pooled difference was 
8.0% (95% CI 2.9% to 13.2%). In the 19 included studies, mean and median ratios of EPDS-5 to 
SCID prevalence were 2.1 and 1.4 times. 
Conclusions: Prevalence estimated based on EPDS-5 ≥7 appears to be substantially higher than 
the prevalence of major depression. Validated diagnostic interviews should be used to establish 
prevalence. 
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Depression during pregnancy and the postpartum period is associated with negative 
implications for maternal health, child health, and families.1-3 Accurate estimation of depression 
prevalence in this population is important for understanding disease burden, making informed 
decisions regarding health care resources, and investigating etiology and challenges associated 
with the condition. Systematic reviews have reported postpartum depression prevalence as 
approximately 7% based on Diagnostic and Statistical Manual (DSM) criteria.4,5 A study of over 
14,000 women in the United States found that 8% of women in pregnancy and 9% of women 
within 12 months postpartum met DSM-IV criteria for depression based on a diagnostic 
interview, compared to 8% among same-aged women.6 
The Maternal Mental Health in Canada, 2018/2019 survey reported that 18% of 7,085 
mothers who gave birth between 5 and 13 months prior reported “feelings consistent with post-
partum depression”7 based on scoring ≥7on a 5-item version of the Edinburgh Postpartum 
Depression Scale (EPDS-5).8 Self-report questionnaires, including the EPDS-5, include some 
symptoms used to diagnose depression, but they do not include all relevant symptoms, 
consideration of functional impairment, or information needed for differential diagnosis.9-11 
Cutoff thresholds on screening tools are typically set to cast a wide net and identify people 
who may benefit from further evaluation, but not to determine whether diagnostic criteria are 
met or estimate prevalence.9-11 Ascertainment of case status and prevalence estimation require 
the use of a validated diagnostic interview, such as the Structured Interview for DSM (SCID).12 
The 10-item EPDS is commonly researched. Less is known about the performance of the EPDS-
5, which has been evaluated only in a single study of 56 women (9 depression cases). Knowledge 
about how it performs in a larger sample would greatly assist interpretation of Maternal Mental 
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Health in Canada results and inform recommendations about its use for describing disease 
burden. 
The present study used data from an individual participant data meta-analysis (IPDMA) on 
EPDS depression screening tool accuracy to compare the proportion of women in pregnancy or 
postpartum with scores ≥7 on the EPDS-5 to prevalence of major depression based on the SCID. 
METHODS 
This study was conducted with data accrued for an IPDMA on EPDS screening accuracy. 
The original IPDMA was registered (PROSPERO; CRD42015024785), and a protocol was 
published.13 The present study was not included in the main EPDS IPDMA protocol. It was 
conducted using methods from a similar study of prevalence based on the full EPDS with the 
protocol uploaded to the Open Science Framework prior to initiating analyses 
(https://osf.io/7gy6p/). 
Identification of Eligible Studies 
Datasets from articles in any language were eligible for the main IPDMA if (1) they 
included EPDS scores for women during pregnancy or within 12 months postpartum; (2) they 
included current Major Depressive Episode (MDE) or Major Depressive Disorder (MDD) 
classifications based on DSM14-16 or International Classification of Diseases17 criteria based on a 
validated semi-structured or fully structured interview; (3) the EPDS and interview were done 
within two weeks of each other; (4) participants were ≥18 years old and not recruited from 
school settings, since the database was originally accrued to assess screening accuracy among 
adults, and school-based screening may have different characteristics; and (5) participants were 
not recruited from psychiatric settings or because they were pre-identified as possibly having 
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depression. Datasets where not all participants were eligible were included if individual eligible 
participants could be identified. 
In the present study we included only data from primary studies that based major 
depression diagnoses on the SCID.12 It is intended for administration by a trained diagnostician, 
requires clinical judgment, and allows probes to be made to clarify responses. We only included 
studies that used the SCID because semi-structured interviews replicate diagnostic standards 
more closely than other types of interviews, and the SCID is by far the most commonly used 
semi-structured diagnostic interview for depression research.18-20 Three previous analyses that 
used large IPDMA databases found that, compared to semi-structured interviews, fully structured 
interviews, designed for administration by lay interviewers, identified more participants with 
low-level depressive symptoms but fewer participants with high-level symptoms as depressed.18-
20 One brief fully structured interview, the Mini International Neuropsychiatric Interview, 
identified far more participants as being depressed across the symptom spectrum.18-20 
Additionally, we excluded datasets that provided only total EPDS scores without item scores. 
This is because item scores were needed to calculate EPDS-5 scores. 
Data Sources, Search Strategy, and Study Selection 
We searched Medline, Medline In-Process & Other Non-Indexed Citations and 
PsycINFO via OvidSP, and the Web of Science Core Collection via ISI Web of Knowledge from 
inception to June 10, 2016. The search was designed by an experienced medical librarian and 
peer-reviewed (Appendix 1).21 We reviewed reference lists from published reviews and queried 
collaborators to attempt to identify non-published studies. Search results were uploaded into 
RefWorks (RefWorks-COS, Bethesda, MD, USA), and, after duplicate removal, into DistillerSR 
(Evidence Partners, Ottawa, Canada) for managing the review process and data extraction. 
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Two investigators independently reviewed titles and abstracts, and if either deemed a study 
potentially eligible, full-text review was done by two investigators, independently. Any 
disagreements were resolved by consensus, with a third investigator consulted if necessary.  
Data Contribution and Synthesis 
Authors of studies with eligible datasets were contacted and invited to contribute de-
identified primary datasets. We emailed corresponding authors of eligible primary studies at least 
three times, with at least two weeks between each email. If there was not a response, we 
attempted phone contact and emailed co-authors. 
For each contributed dataset, we attempted to verify that we could replicate published 
participant characteristics and screening accuracy results, and we resolved any discrepancies, 
consulting with the study investigators. The number of participants and cases from a primary 
study in the IPDMA dataset sometimes differed from numbers in published primary study 
reports for several reasons. First, for some primary studies, not all participants met inclusion 
criteria for our IPDMA. This occurred, for instance, if the period between administration of the 
EPDS and diagnostic interview was longer than two weeks for some participants. Second, some 
primary studies reported accuracy results for depression diagnoses broader than major 
depression, such as “any depressive disorder”, but our reference standard was major depression, 
which would have resulted in a different number of cases than published. Third, in some cases, 
when we compared published results with results from contributed datasets, there were 
discrepancies, and we used the corrected results.  
For primary datasets that used sampling procedures that required weighting, we used the 
weights provided. This occurred, for instance, in studies where all participants with positive 
screens and a random subset of participants with negative screens received a diagnostic 
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interview. For studies where sampling should have been done, but weights were not available, 
we used inverse selection probabilities. 
Statistical Analyses 
For each primary study, we calculated the prevalence of major depression based on the 
SCID, the percentage who scored ≥7 on the EPDS-5, the difference in prevalence between the 
two methods (EPDS-5 ≥ 7 prevalence – SCID major depression prevalence), and the 
corresponding ratio. Then, across studies, we pooled (1) percentage with EPDS-5 ≥7, (2) 
prevalence of SCID major depression, and (3) the differences in prevalence from each study. We 
also determined the mean and median ratio for EPDS-5 ≥7 versus SCID major depression 
prevalence. 
All meta-analyses were conducted in R (R version 3.4.1; R Studio version 1.0.143) using 
the lme4 package. Given the clustered nature of the data, mixed-effects models were used. To 
estimate pooled prevalence values, generalized linear mixed-effects models with a logit link 
function were fit using the glmer function. The logit link accounts for the binary nature of the 
outcome (EPDS-5 ≥7 vs <7; presence vs. absence of SCID major depression). To estimate the 
pooled difference value (fit continuously, given that differences could be positive or negative), a 
linear mixed-effects model was fit using the lmer function. In all analyses, to account for 
correlation between subjects within the same primary study (i.e., the clustering), random 
intercepts were fit for each primary study. To quantify heterogeneity, for each analysis, we (1) 
calculated τ2, which is the estimate of between-study variance, (2) calculated the I2 statistic, 
which quantifies the proportion of total variability due to between-study heterogeneity, and (3) 
estimated the 95% prediction interval for the difference in prevalence, which illustrates the range 
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of difference values that would be expected if a new study were to compare proportion with 
EPDS-5 ≥7 to prevalence based on SCID. 
In post-hoc analyses, we investigated whether differences in prevalence (EPDS-5 ≥7 
prevalence – SCID major depression prevalence) were associated with study and participant 
characteristics. To do this, we fit additional linear mixed-effects models for pooled prevalence 
difference, including age, pregnant versus postpartum status, country human development index 
(“very high”, “high”, or “low-medium”, based on the United Nation’s Human Development 
Index for the year of publication), and study sample size as fixed-effect covariates. 
Ethical Approval 
Since this study involved analysis of previously collected de-identified data and because 
included studies were required to have obtained ethics approval and informed consent, the 
Research Ethics Committee of the Jewish General Hospital determined that ethics approval was 
not required. 
RESULTS 
Search Results and Inclusion of Primary Study Datasets  
There were 3,417 unique citations identified, of which 3,097 were excluded after review of 
titles and abstracts and 212 after full-text review. The 108 remaining articles comprised data 
from 73 unique samples, of which 49 provided data for the main IPDMA; in addition, we were 
provided data from one unpublished study, which was subsequently published. For the present 
study, of the 50 study datasets in the main IPDMA, 21 were excluded because they used a 
diagnostic interview other than the SCID (19 fully structured interviews, 2 other semi-structured 
interviews), and 10 were excluded because item-level data to calculate EPDS-5 scores were not 
available. Thus, datasets from 19 studies were included with 3,958 participants (572 cases of 
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major depression; prevalence 14%). Figure 1 shows the search and dataset inclusion processes, 
and Table 1 shows the characteristics of each included study.22-40 
Depression Prevalence Based on the SCID Versus EPDS-5 ≥7  
The pooled prevalence of SCID major depression was 9.2% (95% confidence interval [CI]: 
6.0% to 13.7%; τ2: 0.901; I2: 94.4%). The pooled percentage of participants who scored ≥7 on 
the EPDS-5 was 16.2% (95% CI: 10.7% to 23.8%; τ2: 1.044; I2: 94.6%). The pooled difference 
from each study was 8.0% (95% CI: 2.9% to 13.2%; τ2: 0.010; I2: 93.7%; 95% prediction 
interval: -13.8% to 29.9%). In the 19 included primary studies, the mean and median ratios of 
proportion of EPDS-5 ≥7 versus SCID prevalence were 2.1 and 1.4, respectively. See Table 1. 
In post-hoc analyses, no study or participant characteristics were significantly associated 
with differences in prevalence, with the exception of age, for which a one-year increase in age 
was associated with a 0.4% (95% CI: 0.2% to 0.7%) decrease in “EPDS-5 ≥4 minus SCID” 
prevalence. 
DISCUSSION 
The Maternal Mental Health in Canada, 2018/2019 survey was conducted by Statistics 
Canada in collaboration with the Public Health Agency of Canada and Health Canada in order to 
address a pressing need for data on maternal mental health problems, including depression.7 One 
previous study had suggested that the EPDS-5 with a cutoff of >7 could be used as a screening 
tool for depression, but it was based on only 9 cases and did not attempt to calibrate the tool to 
estimate prevalence. Results from the present analysis suggest that using a score of ≥7 on the 
EPDS-5 overestimates true prevalence by an absolute value of about 8% or approximately 1.4 to 
2.0 times, depending on whether a mean or median ratio of EPDS-5 to SCID prevalence is used. 
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Despite the heterogeneity across studies in our IPDMA, it is safe to conclude that 
depression prevalence would be substantially overestimated by an EPDS-5 cutoff of >7, although 
it is less easy to determine the amount of overestimation in any given study. This finding is 
similar to other studies that have found that estimates of prevalence derived from cutoff scores 
on screening scales used clinically to detect patients with possible depression vastly over-
estimate prevalence by diagnostic interview.10,11 
The implication of using terminology such as “feelings consistent with post-partum 
depression,” as used in Maternal Mental Health in Canada, 2018/2019 survey is also important. 
Diagnostic or classification thresholds are set to identify individuals with a condition or level of 
impairment that warrants medical attention. Although women who score ≥7 on the EPDS-5 have 
symptoms that are on average more consistent with depression than those below that threshold, 
this does not necessarily mean that they have a diagnosis of depression or require treatment, 
making it very difficult to use the information generated, other than perhaps to compare 
symptom burden across other populations or samples using similar thresholds on the same scale.  
The overestimation of prevalence may also have implications beyond assessing depression 
prevalence itself. For example, the Maternal Mental Health in Canada survey reported that 12% 
of women who were classified as depressed with EPDS >7 had experienced thoughts of harming 
themselves “sometimes” or “often” since the birth of their child. Since many more women were 
classified as depressed than would have met diagnostic criteria based on a validated interview, it 
is possible that the true proportion of women with major depression with thoughts of self-harm 
could be substantially greater than what was estimated. Misclassification not only affects our 
understanding of the frequency of a condition but also how we understand the experiences and 
challenges of those with the condition. 
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There are many examples of national surveys that have used validated diagnostic 
interviews to estimate depression prevalence. In Canada, the Canadian Community Health 
Survey – Mental Health used a version of the World Health Organization’s fully structured 
Composite International Diagnostic Interview (CIDI) to evaluate the prevalence of major 
depressive disorder with a sample of over 25,000 participants.41 In the United States, the 
Epidemiologic Catchment Area Study used another fully structured interview, the Diagnostic 
Interview Schedule (DIS),42 and the National Comorbidity Survey used the CIDI.43 Large cross-
national studies have similarly used the DIS44 and the CIDI.45 The use of validated diagnostic 
interviews requires substantial resources. Using alternative methods, such as the EPDS-5, which 
over-identify depression cases, however, makes it difficult to understand where needs are 
greatest, identify factors associated with onset of mental health problems, and find effective 
solutions. When resources are not available to properly identify cases, alternative research 
questions can be considered. 
STRENGTHS AND LIMITATIONS 
An important strength of the present study is that it included data from 19 primary studies 
with almost 4,000 participants and almost 600 cases of major depression based on the SCID, a 
rigorous semi-structured diagnostic interview designed to classify psychiatric disorders, 
including major depression. We were able to directly compare the proportion of women with 
EPDS-5 ≥7 and prevalence of major depression based on the SCID. A limitation was that 
included studies came from many different countries and reported different prevalence of major 
depression, although the pooled percentage of participants with EPDS-5 ≥7 (16%) was similar to 
that of the Maternal Mental Health in Canada, 2018/2019 survey (18%). Another was that the 
search included studies only through June 2016. There was also considerable heterogeneity 
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across studies in the difference between prevalence estimated with EPDS-5 ≥7 versus the SCID. 
Although age was statistically significantly associated with the difference between EPDS-5 ≥7 
prevalence and SCID major depression prevalence, a one-year difference was associated with 
only a 0.4% difference; given the general similarity in ages of pregnant and postpartum women, 
this would not explain the large differences we found. 
Despite these limitations, there was robust evidence that the EPDS-5 ≥7 generally 
overestimates depression prevalence, and that the magnitude of the overestimation appears to be 
clinically important. 
CONCLUSIONS 
In summary, we found that using EPDS-5 ≥7 to estimate depression overestimates the true 
prevalence of depression substantially. As such, while the 18% reported in the Maternal Mental 
Health in Canada, 2018/2019 survey reflects a certain burden of depressive symptomatology, 
policy-makers may not be able to use it as a benchmark for planning levels of specific services 
because many of those scoring 7 or above on a scale such as the EPDS-5 would not be diagnosed 
with major depressive disorder in a clinical interview. Postpartum depression is an important and 
burdensome condition, and as such, future surveys should use validated diagnostic interviews 
designed for diagnostic calibration to understand prevalence and provide more accurate data to 
use as a benchmark for policymakers to be able to act on need for service to improve outcomes 
for affected mothers and children. 
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Figure 1. Flow diagram of the study selection process 
3417 Unique titles/abstracts 
identified and 
screened for potential 
eligibility
320 Full-text articles 
reviewed for 
eligibility
3097 Titles/abstracts excluded
212 Articles excluded:
• No original data (3)
• No EPDS (4)
• No major depression (38)
• No validated interview to assess major depression (45)
• > 2 weeks between EPDS and diagnostic interview (20)
• Sample selected for known distress, mental health 
diagnosis, or psychiatric setting (72)
• No pregnant or postpartum women (8)
• No adults (6)
• Could not determine eligibility (16)
108 Articles meeting 
eligibility criteria
35 Articles excluded:
• Duplicate participant sample
73 Unique studies
meeting eligibility 
criteria
1 Study the search did not retrieve, and was provided by 
authors of other published eligible studies
50 EPDS studies with 
primary data
24 Eligible studies did not provide primary data
49 Eligible EPDS studies  
contributed primary 
data
31        Studies excluded:
• Did not classify major depression 
with the SCID (21)
• Did not provide item level data (10)
19 Studies included in the 
present study
 27 
Table 1. Difference between EPDS-5 ≥ 7 prevalence and SCID prevalence for each included study 
Author, Year Country 
N 
Total 
N (%) 
EPDS-5 ≥ 7 
N (%) 
SCID Major 
Depression 
% Difference 
EPDS-5 ≥ 7 – 
SCID Major 
Depression 
Ratio: 
EPDS-5 ≥ 7/ 
SCID Major 
Depression 
Barnes, 200922 UK 347 71 (20.5) 25 (7.2) 13.3 2.8 
Beck, 200123 USA 150 20 (13.3) 18 (12.0) 1.3 1.1 
de Figueiredo, 201524a Brazil 242 94 (27.5) 95 (29.6) -2.1 0.9 
Helle, 201525 Germany 225 42 (18.7) 12 (5.3) 13.3 3.5 
Howard, 201826a UK 532 173 (17.0) 130 (9.4) 7.6 1.8 
Leonardou, 200927 Greece 81 13 (16.0) 4 (4.9) 11.1 3.3 
Nakić Radoš, 201328 Croatia 272 32 (11.8) 10 (3.7) 8.1 3.2 
Phillips, 200929  Australia 158 70 (44.3) 42 (26.6) 17.7 1.7 
Prenoveau, 201330a UK 220 51 (14.7) 20 (6.0) 8.7 2.5 
Quispel, 201531 The 
Netherlands 
31 0 (0.0) 0 (0.0) 0.0 ----- 
Rochat, 201332 South Africa 104 66 (63.5) 50 (48.1) 15.4 1.3 
Stewart, 201333a Malawi 186 46 (11.2) 34 (10.1) 1.1 1.1 
Tandon, 201234  USA 89 34 (38.2) 25 (28.1) 10.1 1.4 
Tendais, 201435a  Portugal 141 29 (10.9) 18 (7.6) 3.3 1.4 
Töreki, 201336  Hungary 219 6 (2.7) 7 (3.2) -0.5 0.9 
Töreki, 20137  Hungary 265 20 (7.5) 8 (3.0) 4.5 2.5 
Tran, 201138  Vietnam 361 28 (7.8) 53 (14.7) -6.9 0.5 
Turner, 200939  Italy 29 2 (6.9) 2 (6.9) 0.0 1.0 
Vega-Dienstmaier, 
200240 
Peru 306 148 (48.4) 19 (6.2) 42.2  7.8  
Pooled Results (with 
95% confidence 
interval) 
 3,958 9.2% 
(6.0% to 
13.7%) 
16.2% 
(10.7% to 
23.8%) 
8.0% 
(2.9% to 13.2%) 
Mean = 2.1 
Median = 1.4 
aSampling weights were applied. Counts are based on actual numbers whereas percentages are weighted 
Abbreviations: EPDS: Edinburgh Postnatal Depression Scale; SCID: Structured Clinical Interview for DSM; UK: United 
Kingdom; USA: United States of America 
